Introduction
A CT scan of stomach cancer (Computed Tomography) serves as the cornerstone of modern oncological imaging, providing a non-invasive, high-resolution window into the anatomy of the upper abdomen. Here's the thing — when a physician suspects gastric malignancy—often prompted by symptoms like unexplained weight loss, persistent epigastric pain, or anemia—the contrast-enhanced CT scan is typically the first-line imaging modality ordered for staging and treatment planning. Understanding how to interpret these images is critical not only for radiologists but also for surgeons, medical oncologists, and radiation therapists who rely on this data to determine resectability, select candidates for neoadjuvant therapy, and design targeted radiation fields. Unlike standard X-rays, which offer only a two-dimensional silhouette, a CT scan generates cross-sectional slices that can be reconstructed into three-dimensional models, revealing the precise location, size, and depth of invasion of a gastric tumor. This article provides a complete walkthrough to the radiological appearance, staging criteria, and diagnostic nuances of stomach cancer on CT imaging Simple, but easy to overlook..
Detailed Explanation
The Role of CT in Gastric Cancer Workup
The primary indication for a CT scan for stomach cancer is staging—specifically, determining the TNM classification (Tumor, Nodes, Metastasis) established by the American Joint Committee on Cancer (AJCC). Because of that, while endoscopy with biopsy remains the gold standard for diagnosis (histological confirmation), endoscopy cannot see beyond the mucosal surface. It cannot reliably assess transmural invasion (T-stage), perigastric lymph node involvement (N-stage), or distant metastases to the liver, peritoneum, or lungs (M-stage). This is where the CT scan becomes indispensable. A dedicated gastric cancer protocol CT usually involves a multiphase acquisition: a non-contrast phase (rarely needed but helpful for calcification), an arterial phase (25–35 seconds post-injection), a portal venous phase (60–70 seconds), and occasionally a delayed phase (3–5 minutes). On top of that, the portal venous phase is the workhorse for evaluating liver metastases and lymph nodes, while the arterial phase helps visualize hypervascular tumors or arterial invasion. Oral contrast (positive or negative) is crucial to distend the stomach, separating the walls and preventing a collapsed stomach from mimicking wall thickening—a common pitfall known as "pseudothickening Easy to understand, harder to ignore. Took long enough..
Easier said than done, but still worth knowing.
Technical Parameters for Optimal Imaging
Achieving diagnostic-quality CT scan images of stomach cancer requires strict adherence to technique. Consider this: the patient is typically scanned in the supine position, often with additional prone or decubitus views to redistribute oral contrast and assess dependent areas of the stomach (like the posterior wall of the body and fundus). 5 mm slice thickness) with overlapping reconstructions is mandatory for multiplanar reformation (MPR) into coronal and sagittal planes. Thin-slice acquisition (1–2.These reformations are essential for visualizing the relationship of the tumor to the gastroesophageal junction (GEJ), the pancreatic border, and the transverse mesocolon. Intravenous iodinated contrast is administered via a power injector at 3–4 mL/sec to ensure reliable arterial and venous enhancement. Without adequate distension and vascular opacification, subtle mucosal enhancement patterns—indicative of early T1 disease—or subtle perigastric fat stranding—suggestive of T3/T4 invasion—can be missed entirely.
Step-by-Step Concept Breakdown: Interpreting the Scan
Step 1: Assess Gastric Distension and Wall Thickness
The radiologist first evaluates the degree of gastric distension. A well-distended stomach shows a thin, uniformly enhancing wall (typically < 3–5 mm in the distended state). Focal or diffuse wall thickening (> 10 mm is highly suspicious; 5–10 mm is indeterminate) is the primary sign of malignancy. The morphology is categorized: polypoid (mass protruding into lumen), ulcerative (crater with thickened margins), infiltrative (linitis plastica - diffuse, rigid thickening), or mixed But it adds up..
Step 2: Evaluate Mucosal Enhancement Pattern (T-Staging)
On the arterial and venous phases, the enhancing mucosa is visualized as a bright inner line.
- T1 (Mucosa/Submucosa): The mucosal line is intact or shows a subtle focal defect/nodularity. The outer serosal surface is smooth.
- T2 (Muscularis Propria): The tumor extends into the intermediate low-attenuation muscle layer. The outer serosa remains smooth.
- T3 (Subserosa): The tumor breaches the muscle layer into the perigastric fat. On CT, this appears as irregular serosal contour, perigastric fat stranding (increased attenuation of fat), or a "dirty fat" appearance.
- T4 (Serosa/Adjacent Organs): T4a shows tumor reaching the outer serosal surface (serosal enhancement may be lost). T4b shows direct invasion of adjacent structures (pancreas, transverse colon, liver, spleen, diaphragm, abdominal wall). Loss of the normal fat plane between the stomach and an adjacent organ (> 1 cm contact, irregular margins, or enhancement within the adjacent organ) signifies T4b.
Step 3: Lymph Node Assessment (N-Staging)
Perigastric lymph nodes are evaluated in stations along the lesser/greater curvature, celiac axis, splenic hilum, and hepatoduodenal ligament. Criteria for malignancy include: short axis diameter ≥ 8–10 mm, round shape (loss of fatty hilum), central necrosis (low attenuation center), or clustering of three or more borderline nodes (5–8 mm). Even so, size criteria lack specificity; reactive nodes in gastritis can be enlarged, and microscopic nodal deposits occur in normal-sized nodes.
Step 4: Distant Metastasis Survey (M-Staging)
The scan extends through the chest, abdomen, and pelvis.
- Liver: Hypovascular metastases appear as hypoattenuating lesions on the portal venous phase with peripheral rim enhancement ("target sign").
- Peritoneum: Peritoneal carcinomatosis appears as nodular soft-tissue deposits on the parietal/visceral peritoneum, mesenteric thickening, or "omental caking" (thickened, nodular omentum replacing normal fat).
- Ascites: Malignant ascites often has higher attenuation (> 20 HU) due to protein content.
- Lungs: Pulmonary nodules evaluated on lung windows.
- Ovaries: Krukenberg tumors (bilateral ovarian metastases) in females.
Real Examples
Case Example 1: Advanced Antral Adenocarcinoma (T3N1M0)
A 62-year-old male presents with early satiety and anemia. CT with oral and IV contrast reveals a 4.5 cm ulcerated mass involving the antrum and pylorus. The gastric wall measures 18 mm with heterogeneous enhancement. The outer serosal margin is irregular with distinct perigastric fat stranding extending into the gastrohepatic ligament, but a clear fat plane separates the tumor from the pancreas and transverse colon. Two enlarged perigastric lymph nodes (12 mm and 9 mm short axis) are noted along the lesser curvature. No liver lesions, ascites, or peritoneal deposits are seen. Interpretation: cT3 (subserosal invasion), cN1 (1–2 regional nodes), cM0. This patient is a candidate for neoadjuvant chemotherapy (FLOT protocol) followed by distal gastrectomy with D2 lymphadenectomy And that's really what it comes down to..
Case Example 2: Linitis Plastica with Peritoneal Carcinomatosis (T4aN2M1)
A 48-year-old female with progressive dysphagia and weight loss. The CT shows diffuse, circumferential wall thickening of the entire stomach body and fundus (wall > 20 mm), with loss of
the normal gastric folds and a "laminated" appearance. The gastric wall is poorly defined, blending into the surrounding mesenteric fat. Extensive omental caking is present, with thick, nodular soft tissue replacing the normal omental fat. On the flip side, multiple small, scattered hypoattenuating nodules are visible on the surface of the small bowel mesentery, consistent with peritoneal carcinomatosis. Additionally, several enlarged, necrotic lymph nodes are identified in the celiac axis. That's why Interpretation: cT4a (invasion of visceral peritoneum), cN2 (3–6 regional nodes), cM1 (peritoneal metastases). This represents advanced stage IV disease, where the goal shifts from curative resection to palliative management Not complicated — just consistent..
Case Example 3: Early Gastric Cancer (T1aN0M0)
A 55-year-old female presents with mild dyspepsia. CT imaging shows a localized, 1.5 cm mucosal thickening in the gastric cardia. The gastric wall thickness is only slightly increased (4 mm), and the outer margin is smooth and well-demarcated from the surrounding fat. No suspicious lymphadenopathy or distant lesions are identified. Interpretation: cT1a (mucosal involvement), cN0, cM0. This patient is likely a candidate for endoscopic submucosal dissection (ESD) or early gastrectomy.
Summary Table for Staging Correlation
| TNM Component | Key CT Findings | Clinical Implication |
|---|---|---|
| T (Tumor) | Wall thickness, loss of fat plane, organ invasion | Determines surgical resectability |
| N (Nodes) | Short axis $\ge$ 10mm, necrosis, loss of fatty hilum | Indicates risk of systemic spread |
| M (Metastasis) | Liver lesions, omental caking, ascites | Determines curative vs. palliative intent |
Conclusion
Accurate CT staging of gastric cancer is a complex task that requires a high degree of suspicion for subtle findings, such as minimal fat stranding or small peritoneal nodules. While the TNM system provides a standardized framework for determining prognosis and treatment pathways, the radiologist must remain cognizant of the limitations of CT, particularly regarding the detection of microscopic nodal disease and early mucosal involvement. A multidisciplinary approach—integrating radiological findings with endoscopic biopsy and clinical symptoms—is essential to see to it that patients receive the most appropriate surgical or systemic therapy.